Total Payments
$1,664
2020 Payments
$22.93
Companies
25
Transactions
132
Medicare Patients
1,325
Medicare Billing
$89,617
Payment Breakdown by Category
Food & Beverage$1,664 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,664 | 132 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $240.85 | 15 | $0 (2019) |
| GlaxoSmithKline, LLC. | $232.76 | 22 | $0 (2020) |
| Novo Nordisk Inc | $163.45 | 13 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $136.05 | 14 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.02 | 10 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $82.73 | 7 | $0 (2019) |
| Amarin Pharma Inc. | $80.21 | 6 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.71 | 5 | $0 (2018) |
| Astellas Pharma US Inc | $62.76 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $60.46 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $22.93 | 2 | GlaxoSmithKline, LLC. ($11.58) |
| 2019 | $502.03 | 37 | Amgen Inc. ($92.47) |
| 2018 | $739.97 | 59 | Merck Sharp & Dohme Corporation ($124.03) |
| 2017 | $399.36 | 34 | GlaxoSmithKline, LLC. ($106.47) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2019 | Flowonix Medical Incorporated | Prometra II (Device) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: Pain Management Pump | ||||||
| 09/25/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Neuroscience | ||||||
| 09/05/2019 | Zyla Life Sciences | ZORVOLEX (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Pain Medicine | ||||||
| 08/29/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Neuroscience | ||||||
| 08/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: DIABETES | ||||||
| 07/31/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: DIABETES | ||||||
| 07/12/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Bone Health | ||||||
| 06/26/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.43 | General |
| 06/12/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: AED | ||||||
| 06/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Diabetes | ||||||
| 06/05/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Neuroscience | ||||||
| 05/01/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Diabetes | ||||||
| 04/25/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: AED | ||||||
| 04/17/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Obesity | ||||||
| 04/10/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/09/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 03/13/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: UROLOGY | ||||||
| 03/08/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 194 | 228 | $101,408 | $21,675 |
| 2022 | 2 | 54 | 60 | $14,494 | $3,156 |
| 2021 | 7 | 207 | 224 | $31,286 | $19,258 |
| 2020 | 19 | 870 | 1,172 | $189,421 | $45,527 |
Total Patients
1,325
Total Services
1,684
Medicare Billing
$89,617
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 78 | $36,326 | $7,028 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 32 | $21,157 | $4,258 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $20,069 | $3,727 | 18.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $9,533 | $3,212 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $5,764 | $1,163 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $6,194 | $1,071 | 17.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,975 | $833.91 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $390.00 | $382.20 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 45 | $11,296 | $2,371 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $3,198 | $785.36 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 86 | $13,760 | $8,591 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $4,032 | $3,121 | 77.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 38 | $4,180 | $2,608 | 62.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $2,982 | $1,621 | 54.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 24 | $2,400 | $1,566 | 65.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,892 | $1,330 | 46.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $1,040 | $420.94 | 40.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 174 | 286 | $87,394 | $18,188 | 20.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 83 | 108 | $44,496 | $10,373 | 23.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 62 | 62 | $12,375 | $3,708 | 30.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 13 | 13 | $8,164 | $2,932 | 35.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 22 | 22 | $8,140 | $2,606 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $5,264 | $1,765 | 33.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 65 | 65 | $3,250 | $1,014 | 31.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 184 | 320 | $2,880 | $954.54 | 33.1% |
About Dr. Wesam Elramahi, M.D
Dr. Wesam Elramahi, M.D is a Family Medicine healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2013. The National Provider Identifier (NPI) number assigned to this provider is 1255674263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wesam Elramahi, M.D has received a total of $1,664 in payments from pharmaceutical and medical device companies, with $22.93 received in 2020. These payments were reported across 132 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,664).
As a Medicare-enrolled provider, Elramahi has provided services to 1,325 Medicare beneficiaries, totaling 1,684 services with total Medicare billing of $89,617. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Maywood, IL
- Active Since 03/28/2013
- Last Updated 08/11/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255674263
Products in Payments
- Aimovig (Biological) $162.04
- JANUVIA (Drug) $99.62
- BREO (Drug) $89.21
- XARELTO (Drug) $82.73
- Vascepa (Drug) $80.21
- Trintellix (Drug) $67.36
- JARDIANCE (Drug) $62.73
- ANORO (Drug) $61.61
- TRELEGY ELLIPTA (Drug) $61.22
- Amitiza (Drug) $60.81
- TROKENDI XR (Drug) $54.25
- Victoza (Drug) $53.01
- Prolia (Biological) $50.93
- MYRBETRIQ (Drug) $45.82
- Saxenda (Drug) $38.88
- TOUJEO (Drug) $38.20
- Ozempic (Drug) $34.72
- Livalo (Drug) $33.17
- TRADJENTA (Drug) $33.15
- TRULICITY (Drug) $28.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Maywood
Dr. Amy Buchanan, M.d, M.D
Family Medicine — Payments: $2,875
Family Medicine $2,875
Dr. Irma Perez, M.d, M.D
Family Medicine — Payments: $1,655
Family Medicine $1,655
Raymond Loza, Md, MD
Family Medicine — Payments: $752.96
Family Medicine $752.96
Julianna Kacheris, Md, MD
Family Medicine — Payments: $499.94
Family Medicine $499.94
Dr. Emanuel Favela, M.d, M.D
Family Medicine — Payments: $458.90
Family Medicine $458.90
Maged Basilios, Md Inc, MD INC
Family Medicine — Payments: $305.97
Family Medicine $305.97